Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients

Frontiers in Immunology

Volumn 3, Issue DEC, 2012, Pages

  Egaña Gorroño, Lander ^a   Martínez, Esteban ^b   Escribà, Tuixent ^a   Calvo, Marta ^b   Gatell, José M ^a,b   Arnedo, Mireia ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Copy number variation; Coronary heart disease; Hiv; Host genetics; LPA gene

Indexed keywords

EID: 84874235671     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00367     Document Type: Article

References (20)

1. Berglund, L., and Ramakrishnan, R. (2004). Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler. Thromb. Vasc. Biol. 24, 2219-2226.
2. Boerwinkle, E., Leffert, C. C., Lin, J., Lackner, C., Chiesa, G., and Hobbs, H. H. (1992). Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90, 52-60.
3. Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., et al. for the PROCARDIS Consortium. (2009). Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N. Eng. J. Med. 361, 2518-2528.
4. Friis-Møller, N., Sabin, C. A., Weber, R., d'Arminio Monforte, A., El-Sadr, W. M., Reiss, P., et al. (2003). Combination antiretroviral therapy and the risk of myocardial infarction. N. Engl. J. Med. 349, 1993-2003.
5. Gavish, D., Azrolan, N., and Breslow, J. L. (1989). Plasma lp(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. J. Clin. Invest. 84, 2021-2027.
6. Hansson, G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695.
7. Kannel, W. B., McGee, D., and Gordon, T. (1976). Cardiovascular risk factors. Insights from Framingham Heart Study. Am. J. Cardiol. 38, 46-51.
8. Kraft, H. G., Köchl, S., Menzel, H. J., Sandholzer, C., and Utermann, G. (1992). The apolipoprotein(a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum. Genet. 90, 220-230.
9. Kraft, H. G., Lingenhel, A., Köchl, S., Hoppichler, F., Kronenberg, F., Abe, A., et al. (1996). Apolipopro-tein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 16, 713-719.
10. Lackner, C., Cohen, J. C., and Hobbs, H. H. (1993). Molecular definition of the extreme size polymorphism in apolipoprotein (a). Hum. Mol. Genet. 2, 933-940.
11. Lanktree, M. B., Anand, S. S., Yusuf, S., and Hegele, R. A. (2010). Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein (a) in south Asians, Chinese and European Caucasians. Circ. Cardiovasc. Genet. 3, 39-46.
12. Lanktree, M. B., Rajakumar, C., Brunt, J. H., Koschinsky, M. L., Connelly, P. W., and Hegele, R. A. (2009). Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyp-ing using qPCR. J. Lipid Res. 50, 768-772.
13. McLean, J. W., Tomlinson, J. E., Kuang, W. J., Eaton, D. L., Chen, E. Y., Fless, G. M., et al. (1987). cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330, 132-137.
14. Ohira, T., Schreiner, P. J., Morrisett, J. D., Chambless, L. E., Rosamond, W. D., and Folsom, A. R. (2006). Lipopro-tein (a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 37, 1407-1412.
15. Paultre, F., Pearson, T. A., Weil, H. F., Tuck, C. H., Myerson, M., Rubin, J., et al. (2000). High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and White men. Arterioscler. Thromb. Vasc. Biol. 20, 2619-2624.
16. Rhoads, G. G., Dahlen, G., Berg, K., Morton, N. E., and Dannenberg, A. L. (1986). Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256, 2540-2544.
17. Ridker, P. M., Hennekens, C. H., and Stampfer, M. J. (1993). A prospective study of lipoprotein (a) and the risk of myocardial infarction. JAMA 270, 2195-2199.
18. Sandholzer, C., Saha, N., Kark, J. D., Rees, A., Jaross, W., Dieplinger, H., et al. (1992). Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler. Thromb. 12, 1214-1226.
19. The Joint European Society of Cardiology/American College of Cardiology Committee. (2000). Myocardial Infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur. Heart J. 21, 1502-1513.
20. Triant, V. A., Lee, H., Hadigan, C., and Grinspoon, S. K. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with HIV disease. J. Clin. Endocrinol. Metab. 92, 2506-2512.